OSI Pharmaceuticals

OSI Pharmaceuticals (United States) has no DMF, CEP or site registration linked in our records. 2 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “OSI Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/osi-pharmaceuticals

Overview

OSI Pharmaceuticals is a biotechnology company focused on developing and commercializing oncology therapies. It is a subsidiary of Astellas Pharma.

Therapeutic areas

FDA compliance signals

2 FDA enforcement records linked to this company.

  • 4832010-09-22

    Late submission of 15-day report

  • 4832010-09-22

    Submission of report follow-up

For suppliers

Is this OSI Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.